Hi Shuchi,

We don’t have any researchers working with opioids in a way that would make an accidental laboratory exposure clinically significant. (Ingestion would be a problem, but then ingestion of most things they are researching with would be a problem!) Most laboratory accidents involve contact with intact skin (small amounts, easily flushed), needlesticks which would be a miniscule dose, or respiratory exposure which shouldn’t be a concern working with opioids. At least we haven’t had a protocol that involved an ultrapotent experimental opioid that would pose that concern.

Melanie

Melanie Swift, MD, MPH

(she/her)
Vice Chair, Division of Public Health, Infectious Diseases and Occupational Medicine

Medical Director, Mayo Clinic Physician Health Center

Associate Medical Director, Occupational Health Service

_______________________________
Mayo Clinic
200 First Street SW
Rochester, MN 55905

From: MCOH-EH <mcoh-eh-bounces+swift.melanie=mayo.edu@mylist.net> On Behalf Of Shuchi Agarwal
Sent: Tuesday, November 1, 2022 12:07 PM
To: mcoh-eh@mylist.net
Subject: [EXTERNAL] [MCOH-EH] Narcan availability in research labs

Hello everyone,

I am wondering if any of your institutions have a procedure for research labs that work with opioids to have narcan available in the case of an accidental exposure?

If so, would you be willing to connect to discuss further?

Thanks in advance. 

Warm regards,

Shuchi 

Shuchi Agarwal MD MPH

Assistant Attending Employee Health 

Memorial Sloan Kettering Cancer Center